# Metformin Use in Rheumatoid Arthritis

> **NCT03863405** · PHASE2 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 60 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Metformin
- **DRUG:** Conventional DMARDs
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03863405
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-09
- **Primary completion:** 2020-01-09
- **Final completion:** 2020-01-09
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-05-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03863405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03863405, "Metformin Use in Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03863405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*